Moderna Inc had a net loss of $-3 billion, during the twelve month ending in the second quarter 2026.
The Healthcare sector has seen employees of 60 other companies achieving higher income per employee. While Moderna Inc 's total ranking has deteriorated compared to the previous quarter from 3429 to 3537.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRNA Net Income per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Net Income Change	-	-	-	-	-
Net Income per Employee (TTM) $	-670,426	-679,574	-600,426	-662,979	-617,660
MRNA's Total Ranking	# 3537	# 3429	# 2635	# 3221	# 3032
Seq. Net Income Change	-	-	-	-	-

MRNA Company Profile >> Back to MRNA Efficiency Comparisons >> Compare MRNA Net Income per Employee to its Competitors

MRNA Net Income per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 61
Healthcare Sector	# 502
Overall Market	# 3537

Net Income per Employee Statistics
High	Average	Low
$ 3,114,468	$ 144,222	$ -1,269,787
(Mar 31 2022)		(Mar 31 2024)

News about Moderna Inc Income per employee

Blackstone Life Sciences Collaborates with Moderna to Uphold Flu Treatment and Prevention

In an exciting development within the biotechnology and pharmaceutical industry, Blackstone Life Sciences (Blackstone) has announced a groundbreaking collaboration with Moderna, Inc. (Moderna) to support the latter s influenza (flu) program. Under a new development and commercialization funding agreement, Blackstone will provide up to $750 million to fuel Moderna s efforts in developing innovative mRNA vaccines targeting respiratory illnesses. This collaboration marks a significant milestone in the field of medical advancements, as Moderna has consistently demonstrated its exceptional ability to impact human health through revolutionary vaccine technologies.
The Financial Landscape:
Moderna s exceptional potential in revolutionizing the medical field is accentuated by its collaborations with investment firms such as Blackstone. While Moderna has exhibited a net loss of $-4 billion during the twelve months ending in the fourth quarter of 2023, this collaboration will provide immense support and resources to accelerate the development of their influenza program. The partnership with Blackstone Life Sciences demonstrates the industry s confidence in Moderna s capabilities and long-term prospects.

Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector

Income per Employee

Income 12 month ending Jun 30 2026

Number of Employees Jun 30 2026

Date modified: 2026-08-31T06:04:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.